AplusA COVID-19 Business Continuity Plan

In light of the current global COVID-19 outbreak, we wanted to share key points from AplusA's...

DLBCL Case Study: Enhancing Patient Journey Research with Social Media Listening

Using the example of a recent AplusA study in Diffuse Large B-Cell Lymphoma (DLBCL), we consider...

Patient Insights from AplusA’s Multiple Myeloma Tracker

A thoughtfully developed tracker can provide deep insights on any therapeutic area. Using the...

Multiple Myeloma Market Dynamics Revealed by AplusA Tracker

A thoughtfully developed tracker can provide deep insights on any therapeutic area. Using the...

Brand Performance Insights from AplusA's Multiple Myeloma Tracker

A thoughtfully developed tracker can provide deep insights on any therapeutic area. Using the...

Key Insights from a Multiple Myeloma Tracker

A thoughtfully developed tracker can provide deep insights on any therapeutic area. Using the...

EphMRA 2019: Future Leaders Winning Case Study

Availability vs Patient Usage of New Digital GP Services

New apps and devices are constantly being designed with the intention of simplifying or...

Doctors and New Technology: The Early Adopters

Increased access to information and new health-related products and services creates new...

Doctors and New Technology: The Behaviors of an Average GP

Digital and connected health devices and services are changing how we interact with HCPs accross...